Johanna Mercier

2021

In 2021, Johanna Mercier earned a total compensation of $6.6M as Chief Commercial Officer at Gilead Sciences, a 16% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$1,557,231
Option Awards$1,012,485
Salary$1,050,428
Stock Awards$2,620,663
Other$311,790
Total$6,552,597

Mercier received $2.6M in stock awards, accounting for 40% of the total pay in 2021.

Mercier also received $1.6M in non-equity incentive plan, $1M in option awards, $1.1M in salary and $311.8K in other compensation.

Rankings

In 2021, Johanna Mercier's compensation ranked 1,900th out of 12,397 executives tracked by ExecPay. In other words, Mercier earned more than 84.7% of executives.

ClassificationRankingPercentile
All
1,900
out of 12,397
85th
Division
Manufacturing
712
out of 5,492
87th
Major group
Chemicals And Allied Products
268
out of 2,367
89th
Industry group
Drugs
228
out of 2,090
89th
Industry
Biological Products, Except Diagnostic Substances
65
out of 452
86th

Pay ratio

Johanna Mercier's Pay$6,552,597
Median Employee's Pay$211,687
Pay Ratio

31

to 1

In 2021, the annual total compensation of Johanna Mercier was $6,552,597.

The annual total compensation of the median employee at Gilead Sciences was $211,687.

The ratio of Johanna Mercier's pay to the pay of median employee was therefore 31 to one.

Source: SEC filing on March 24, 2022.

Mercier's colleagues

We found four more compensation records of executives who worked with Johanna Mercier at Gilead Sciences in 2021.

2021

Daniel O'Day

Gilead Sciences

Chief Executive Officer

2021

Merdad Parsey

Gilead Sciences

Chief Medical Officer

2021

Andrew Dickinson

Gilead Sciences

Chief Financial Officer

2021

Brett Pletcher

Gilead Sciences

General Counsel

News

You may also like